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Background: Although item response theory (IRT) appears to be increasingly used within health care research in
general, a comprehensive overview of the frequency and characteristics of IRT analyses within the rheumatic field is
lacking. An overview of the use and application of IRT in rheumatology to date may give insight into future
research directions and highlight new possibilities for the improvement of outcome assessment in rheumatic
conditions. Therefore, this study systematically reviewed the application of IRT to patient-reported and clinical
outcome measures in rheumatology.
Methods: Literature searches in PubMed, Scopus and Web of Science resulted in 99 original English-language
articles which used some form of IRT-based analysis of patient-reported or clinical outcome data in patients with a
rheumatic condition. Both general study information and IRT-specific information were assessed.
Results: Most studies used Rasch modeling for developing or evaluating new or existing patient-reported
outcomes in rheumatoid arthritis or osteoarthritis patients. Outcomes of principle interest were physical functioning
and quality of life. Since the last decade, IRT has also been applied to clinical measures more frequently. IRT was
mostly used for evaluating model fit, unidimensionality and differential item functioning, the distribution of items
and persons along the underlying scale, and reliability. Less frequently used IRT applications were the evaluation of
local independence, the threshold ordering of items, and the measurement precision along the scale.
Conclusion: IRT applications have markedly increased within rheumatology over the past decades. To date, IRT has
primarily been applied to patient-reported outcomes, however, applications to clinical measures are gaining
interest. Useful IRT applications not yet widely used within rheumatology include the cross-calibration of instrument
scores and the development of computerized adaptive tests which may reduce the measurement burden for both
the patient and the clinician. Also, the measurement precision of outcome measures along the scale was only
evaluated occasionally. Performed IRT analyses should be adequately explained, justified, and reported. A global
consensus about uniform guidelines should be reached concerning the minimum number of assumptions which
should be met and best ways of testing these assumptions, in order to stimulate the quality appraisal of performed
IRT analyses.
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Since there is no gold standard for the assessment of
disease severity and impact in most rheumatic condi-
tions, it is common practice to administer multiple out-
come measures to patients. Initially, the severity and
impact of most rheumatic conditions was typically evalu-
ated with clinical measures (CMs) [1,2] such as labora-
tory measures of inflammation like the erythrocyte
sedimentation rate [3] and physician-based joint counts
[4,5]. Since the eighties of the last century, however,
rheumatologists have increasingly started to use patient-
reported outcomes (PROs) [1,2]. As a result, a wide var-
iety of PROs are currently in use, varying from single
item visual analogue scales (e.g. pain or general health)
to multiple item scales like the health assessment ques-
tionnaire (HAQ) [6] which measures a patient’s func-
tional status and the 36-item short form health survey
(SF-36) which measures eight dimensions of health
related quality of life [7].
Statistical methods are essential for the development
and evaluation of all outcome measures. By far, most
health outcome measures have been developed using
methods from classical test theory (CTT). In recent
years, however, an increase in the use of statistical meth-
ods based on item response theory (IRT) can be
observed in health status assessment [8-10]. Extensive
and detailed descriptions of IRT can be found in the lit-
erature [11-14]. In short, IRT is a collection of probabil-
istic models, describing the relation between a patient’s
response to a categorical question/item and the under-
lying construct being measured by the scale [11,15]. IRT
supplements CTT methods, because it provides more
detailed information on the item level and on the person
level. This enables a more thorough evaluation of an
instrument’s psychometric characteristics [15], including
its measurement range and measurement precision. The
evaluation of the contribution of individual items facili-
tates the identification of the most relevant, precise, and
efficient items for the assessment of the construct being
measured by the instrument. This is very useful for the
development of new instruments, but also for improving
existing instruments and developing alternate or short
form versions of existing instruments [16]. Additional-
ly, IRT methods are particularly suitable for equating dif-
ferent instruments intended to measure the same
construct [17] and for cross-cultural validation purposes
[18]. Finally, IRT provides the basis for developing item
banks and patient-tailored computerized adaptive tests
(CATs) [9,19,20].
Although IRT appears to be increasingly used within
health care research in general, a comprehensive over-
view of the frequency and characteristics of IRT analyses
within the rheumatic field is lacking. The Outcome Mea-
sures in Rheumatology (OMERACT) network recentlyinitiated a special interest group aimed at promoting the
use of IRT methods in rheumatology [21]. An overview
of the use and application of IRT in rheumatology to
date may give insight into future research directions and
highlight new possibilities for the improvement of out-
come assessment in rheumatic conditions. Therefore,
the aim of this study was to systematically review the ap-
plication of IRT to clinical and patient-reported outcome
measures within rheumatology.
Methods
Search strategy
Figure 1 presents an overview of the various stages fol-
lowed during the search process, starting with an exten-
sive literature search in April 2012 to identify all eligible
studies up to and including the year 2011. Electronic
database searches of PubMed, Scopus, and Web of Sci-
ence were carried out, using the terms 'Item response
theor*' OR 'Item response model*' OR 'latent trait theor*'
OR Rasch OR Mokken, in combination with Rheumat*
OR Arthros* OR arthrit*.
Inclusion and exclusion criteria
Only original research articles written in English were
included. Articles were considered original when they
included original data and when they performed analyses
on this data in order to achieve a defined study object-
ive. To be included, studies should present an applica-
tion of IRT in a sample of which at least 50% had some
kind of rheumatic disease. In cases where less than 50%
of the study sample consisted of rheumatic patients (i.e.
inflammatory rheumatism, arthrosis, soft tissue rheuma-
tism), the study was only included when the rheumatic
sample was analysed separately from the rest of the sam-
ple. Reviews, letters, editorials, opinion papers, abstracts,
posters, and purely descriptive studies were excluded.
No limitations were set for study design.
Study identification and selection
The search strategy resulted in a total of 385 studies.
After the removal of 189 duplicates, 196 unique articles
were identified. Two reviewers independently screened
all 196 studies for relevance based on the abstract and
title identified from the initial search. If no evident in-
clusion or exclusion reasons were identified, the full-text
was examined. In total, 103 studies did not meet inclu-
sion criteria and were excluded. The main reasons for
exclusion were: the study population (i.e. the study
population was not clearly defined or the study con-
tained a rheumatic sample <50% of the total sample
which was not separately analysed), the statistical ana-
lyses (i.e. no IRT application), and the article type (i.e.
non-original research). Figure 1 includes an overview of
Figure 1 Flowchart of the search process.
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removed.
Data extraction
First, two reviewers independently evaluated a random
sample of 15 articles. Both general study information as
well as IRT-specific information were extracted, using a
purpose-made checklist (Additional file 1) based on both
expert input and important issues as mentioned inTennant and Conaghan [22], Reeve and Fayers [15], and
Orlando [23]. Inter-rater agreement of the evaluated
variables was moderate to high, with Cohen’s kappa ran-
ging from 0.60 to 1.00. Most of the disagreements were
caused by differing interpretations of some of the
extracted variables. For instance, one of the reviewers
interpreted the checklist on “performed analyses” as per-
formed analyses using IRT based methods only, whereas
the other reviewer interpreted it more broadly including
classical test theory methods as well (the latter being the
correct method). Consensus about these differences was
reached by discussion. Next, one of these reviewers also
evaluated the remaining 84 articles.
General study information
General information concerned the author(s), publica-
tion year, study population, the populations’ country of
origin, total number of participants (N), study design of
the IRT analyses (i.e. cross-sectional or longitudinal),
type of outcome measure (PRO or CM), and main meas-
urement intention (e.g. quality of life, pain, overall phys-
ical functioning).
Purpose of analyses
The purpose of the analyses was determined by the main
goal the author(s) of the article pursued (e.g. the devel-
opment, evaluation, comparison, or cross-cultural valid-
ation of instruments).
Specific IRT analyses
Before a researcher can perform IRT analyses, an appro-
priate IRT model should be selected. Unidimensional
models are most widely applied, the simplest being the
Rasch model which assumes that the items are equally
discriminating and vary only in their difficulty. The 2-
parameter logistic model (2-PL model) extends the
Rasch model by assuming that the items have a varying
ability to discriminate among people with different levels
of the underlying construct [11,15,19,23]. These models
can be specified further for polytomous items. The rat-
ing scale model, graded response model, modified
graded response model, partial credit model, and gener-
alized partial credit model can be applied in case of
ordered categorical responses. The nominal response
model can be applied when response categories are not
necessarily ordered [11,15,19,23,24]. The rating scale
model and the partial credit model are generalizations of
the Rasch model, the other models are generalizations of
the 2-PL model. In addition to these unidimensional mod-
els, multidimensional models and specific non-parametric
models like the Mokken model [25,26] have been devel-
oped. Differences in model assumptions should be taken
into account when choosing a model and model choice
should be motivated by taking the discrimination equality
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egories into consideration [15,22-24].
The applied IRT software and the corresponding item
and person parameter estimation method(s) should also
be cited, since not all software packages report the find-
ings in the same way [22] and because the use of different
estimation methods may result in different parameter esti-
mates [11].
To make IRT results interpretable and trustworthy,
three principal assumptions should be evaluated when
applying a unidimensional IRT model [15,23]. The first
assumption concerns unidimensionality, meaning that
the set of test items measure only a single construct
[11,15,22,23]. Analyses for checking the unidimensional-
ity can include different types of factor analysis of the
items or the residuals. A more advanced method would
be to compare a unidimensional IRT model with a
multidimensional IRT model, for instance using a likeli-
hood ratio test. The second (related) assumption con-
cerns local independence of the items. When this
assumption is violated this may indicate that the items
have more in common with each other than just the sin-
gle underlying construct [11,15,22,23]. This may either
point to response dependency (e.g. overlapping items in
the scale) or to multidimensionality of the scale [22]. It
can lead to biased parameter estimates and wrong deci-
sions about, for instance, item selection [15]. Local inde-
pendence can be tested by a factor analysis of the
residual covariations, or with more specific statistics tar-
geted at responses to pairs of items [12]. The third as-
sumption concerns the model’s appropriateness to
reflect the true relationship among the underlying con-
struct and the item responses [11,15,22,23]. This can be
examined with both item and person fit statistics. More
information about these assumptions and suggestions
about which aspects to report can be found in the litera-
ture [11,15,22,23].
Other useful IRT applications include the evaluation of
the presence of differential item functioning, the reliabil-
ity and measurement precision, the ordering of the re-
sponse categories or item thresholds, and the
hierarchical ordering and distribution of persons and
items along the scale of the underlying construct.
Differential item functioning (DIF, also called item
bias) is present when patients with similar levels of the
underlying construct being measured respond differently
to an item [15,22]. Commonly examined types of DIF
are DIF across gender and age [22].
Global IRT reliability is equivalent to Cronbach’s
alpha, with the difference that not the raw score but the
IRT score is being used in its calculation. Which specific
global reliability statistics are presented usually depends
on the software package used. Contrary to CTT meth-
ods, IRT also provides information about the localreliability [12] and, related to this, the instrument’s
measurement precision along the scale of the underlying
construct.
With rating scale analysis, the ordering of the response
categories or item thresholds can be checked, enabling
the evaluation of the appropriateness or redundancy of
the response categories [15]. Likewise, the hierarchical
ordering and/or distribution of persons and items along
the scale can be analysed to determine the measurement
range of the outcome measure and to determine
whether the items function well for the included popula-
tion sample or whether there is a mismatch between
them [23].Results
General information of included studies
The initial database search yielded a total of 93 eligible
studies. Six additional studies were identified by manual
reference checks of the selected studies. This resulted in
a final selection of 99 studies (Additional file 2). Figure 2
shows that the prevalence of IRT analysis within
rheumatology increased markedly over the past decades.
This is consistent with conclusions from Hays et al. [19],
and with findings from Belvedere and Morton [8] who
examined the frequency of Rasch analyses in the devel-
opment of mobility instruments.
Table 1 presents an overview of the most prominent
results. By far, most research was carried out with
patients from the United States or the United Kingdom,
but data from patients from the Netherlands and Canada
were also regularly used. The vast majority of studies
involved cross-sectional IRT analyses. It could also be
observed that an increasing number of studies perform
longitudinal IRT analyses since the 21st century, as
represented by a rise of DIF testing over time.
Study samples varied from as little as 18 persons in
the study of Penta et al. [27] to as many as 16519 per-
sons in the study conducted by Wolfe et al. [28]. Most
studies (92.9%) performed analyses on a population sam-
ple of at least 50 persons.
In 85 of the 99 studies IRT analyses were applied to
PROs. The remaining 14 studies applied IRT to CMs.
The vast majority of the studies applied IRT to data
gathered from patients suffering from rheumatoid arth-
ritis (RA) or osteoarthritis (OA).
Outcome measures of overall physical functioning and
quality of life were most frequently being analysed. To a
lesser extent, studies applied IRT to PRO measures of
specific functioning [27,29-37], pain [35,38-43], psycho-
logical constructs [44-46], and work disability [47-51].
Studies also applied IRT to CMs such as measures of
disease activity [52-54] and disease damage or radio-
graphic severity [55-57].
Figure 2 Number of published articles reporting the application of IRT within rheumatology.
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Most common main goals for both the PRO- and the
CM-studies were the development or evaluation of new
measures, the evaluation of existing measures, and the
development or evaluation of alternate or short form
versions of an existing measure. In addition, several
studies aimed to cross-culturally validate a patient-
reported or clinical measure. IRT was rarely applied for
the development of item banks [17,58] or computerized
adaptive tests [59,60].
Specific IRT analyses
IRT model and software
The vast majority of IRT applications within rheumatology
involved Rasch analyses, although a clear specification and
rationale of the applied Rasch model was not always given.
Few studies used a two-parameter IRT model or Mokken
analysis. Most analyses were carried out with the software
packages Bigsteps/Winsteps or RUMM.
A motivation of the model choice was only provided
in 27.3% of the studies. Likewise, the item and person
parameter estimation methods were rarely specified
(8.1% and 4.0% of the studies, respectively).
IRT assumptions
The assumption of unidimensionality was tested in ap-
proximately three quarters of the studies. Methods used
for this purpose mainly concerned some type of factor
analysis (confirmatory/exploratory factor analysis or prin-
cipal component analysis) or the examination of specific
IRT statistics (e.g. whether the overall model fit or the
item fit values were larger than a pre-specified cut-
off point). No studies were found where unidimensional
IRT models were contrasted with multidimensional IRT
models.
A possible violation of the assumption of local inde-
pendence was evaluated in only one of the CM studies,
and in only 18.8% of the studies concerning a PRO.Evaluation of the studies also indicated there was no
clear agreement on how to evaluate this assumption,
given the variety of methods used.
The assumption of the appropriateness of the model
was evaluated by approximately 91% of the studies.
When applied, roughly half of the cases evaluated overall
fit (PRO: 51.9%, CM: 53.8%), almost all evaluated item fit
(PRO: 97.4%, CM: 100.0%), but a much smaller percent-
age evaluated person fit statistics (PRO: 33.8%, CM:
30.8%).
Additional IRT analyses
More than half of the studies used IRT to examine DIF.
When applied, analyses varied from cross-sectional DIF
across gender (PRO: 80.0%, CM: 66.7%), age (PRO: 76.0%,
CM: 66.7%), disease duration (PRO: 36.0%, CM: 16.7),
countries/cultures/ethnicity (PRO: 18.0%, CM: 16.7%),
and disease type (PRO: 10.0%, CM: 16.7%), to longitudinal
DIF analyses over time (PRO: 28.0%, CM: 33.3%).
Other commonly performed IRT analyses included
analyses of the global reliability, the hierarchical ordering
and distribution of items and persons, and rating scale
analyses (i.e. the ordering of the response categories or
item thresholds). In addition, a small number of PRO-
studies reported IRT analyses regarding the measure-
ment precision of the scale, whereas only 1 of the CM
studies evaluated this.
Discussion
IRT offers a powerful framework for the evaluation or
development of existing and new outcome measures.
This is the first study that systematically reviewed the
extent to which IRT has been applied to measure-
ments from rheumatology. Results showed a marked
increase in IRT applications within the rheumatic field
from the late eighties up to now. Even though most
research focussed on PROs, IRT also appeared to be
useful for application to CMs. Some opportunities for
Table 1 Overview of the most prominent results
Variable PRO-studies CM-studies Total-studies
n % * n % * n % *
Country
US 26 30.6 4 28.6 30 30.3
UK 24 28.2 2 14.3 26 26.3
Netherlands 11 12.9 4 28.6 15 15.2
Canada 10 11.8 1 7.1 11 11.1
Other 32 37.6 5 35.7 37 37.4
Design
Cross-sectional 76 89.4 14 100.0 90 90.9
Longitudinal 13 15.3 2 14.3 15 15.2
Disease condition
RA 43 50.6 5 35.7 48 48.5
OA 31 36.5 3 21.4 34 34.3
Other 31 36.5 7 50.0 38 38.4
Measurement intention
Overall physical
functioning
33 38.8 2 14.3 35 35.4
Quality of life 26 30.6 2 14.3 28 28.3
Specific functioning 10 11.8 0 0.0 10 10.1
Pain 7 8.2 0 0.0 7 7.1
Psychological constructs 3 3.5 0 0.0 3 3.0
Work disability 5 5.9 0 0.0 5 5.0
Disease activity 0 0.0 3 21.4 3 3.0
Disease damage or
radiographic severity
0 0.0 3 21.4 3 3.0
Other 11 12.9 4 28.6 15 15.2
Main goal
Development/evaluation
new measures
25 29.4 2 14.3 27 31.4
Evaluation existing
measures
31 36.5 6 42.9 37 37.4
Development/evaluation
alternate/short form
11 12.9 2 14.3 13 13.1
Development item
bank or CAT
4 4.7 0 0.0 4 4.0
Cross-cultural validation 7 8.2 2 14.3 9 9.1
Other 11 12.9 3 21.4 14 14.1
Software
Bigsteps/Winsteps 28 32.9 3 21.4 31 31.3
RUMM 29 34.1 6 42.9 35 35.4
Other/not specified 29 34.1 5 35.7 34 34.3
IRT model
Rasch 72 84.7 12 85.7 84 84.8
2-PLM 13 15.3 1 7.1 14 14.1
Mokken 3 3.5 1 7.1 4 4.0
Table 1 Overview of the most prominent results
(Continued)
IRT analyses
Unidimensionality 65 76.5 10 71.4 75 75.8
Local independence 16 18.8 1 7.1 17 17.2
Appropriateness
model (fit analyses)
77 90.6 13 92.9 90 90.9
DIF 50 58.8 6 42.9 56 56.6
Person/item
separation/reliability
52 61.2 10 71.4 62 62.6
Hierarchical ordering/
distribution of items/
persons
57 67.1 9 64.3 66 66.7
Rating scale analysis 30 35.3 7 50.0 37 37.4
Measurement precision
of the scale
10 11.8 1 7.1 11 11.1
PRO: patient-reported outcome (N=85), CM: clinical measure (N=14), RA:
rheumatoid arthritis, OA: osteoarthritis, CAT: computerized adaptive test, IRT:
item response theory, 2-PLM: 2 parameter logistic model, DIF: differential item
functioning.
* Note that some studies can be assigned to multiple subcategories, therefore,
the sum of the percentages within a category exceeds 100%.
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lyses and reporting of IRT studies were also pointed
out.
IRT can be applied for various purposes. First, IRT
analysis is useful for the development and evaluation of
new measures [22]. For instance, Helliwell et al. [32]
developed a foot impact scale to assess foot status in RA
patients. Rasch modeling was used to facilitate item re-
duction by selecting items which were free of DIF and
fitted model expectations. Where the CTT methods
often discard items at the extremes of the measurement
range because too few patients answer them affirma-
tively, IRT includes these items since they provide im-
portant information at the extremes of the measurement
range [61].
IRT is also suitable for the evaluation of existing (or-
dinal) outcome measures. For example, when evaluating
an instrument’s included response categories it can be
determined whether they perform as intended or
whether categories should be collapsed into fewer
options or expanded into more options [22]. Further-
more, it can be evaluated whether the items in the out-
come measure form a unidimensional scale as expected
or whether item deletion is necessary [22].
Another favourable feature of IRT is that it is
expressed at the item level instead of test level as in
CTT [11]. By evaluating the performance of individual
items, alternate or short form versions of existing mea-
sures can be developed. For example, Wolfe et al. [62]
developed an alternate version of the HAQ [6,63],
known as the HAQ-II, specifically targeted at patients
with a relatively high physical functioning.
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item level is the robust assessment of DIF, as reflected in
the high proportion of performed DIF analyses. Never-
theless, the full potential of modeling at the item level is
not yet being used, given the low percentage of studies
evaluating the items’ performance (i.e. measurement
precision and local reliability) along the scale.
When comparing the studies focusing on RA patients
with those focusing on OA patients, the measurement
intensions of the analysed instruments and the applied
IRT models were highly comparable. However, a notable
difference was found in the main goals of these studies.
Where the RA studies pursued widely varying main
goals, including the development of new instruments,
the evaluation of existing instruments, the comparison
of different instruments, and cross-cultural validation,
the studies on OA patients generally focused on the
evaluation of existing instruments only.
There are several IRT applications which have not yet
been (frequently) used within rheumatology. One IRT
application which appears to be still in its infancy within
rheumatology, but which is likely to gain importance in
the future, is the development of computerized adaptive
tests (CATs) [2]. When testing by means of a CAT, every
patient receives a test which is tailored (adapted) to his
or her level on the underlying construct being measured.
Consequently, each patient can be administered different
sequences and numbers of items, drawn from a large
item bank. By applying CATs, tests can be shortened
without any loss of measurement precision, reducing
measurement burden for both the patient and the
rheumatologist [1,2,9-11,16].
The potential advantages of cross-calibration is an-
other IRT application which has not yet been recognized
within rheumatology. As opposed to CTT methods, the
item responses are regressed on separate item and per-
son parameters in IRT [11]. This means that the defin-
ition of item parameters is independent of the sample
receiving the test and the definition of person para-
meters is independent of the test items given. This sep-
aration of parameters facilitates the cross-calibration of
various outcome measures based on the same underlying
construct [11,64], making their scores comparable with
each other.
As discussed earlier, it is important to test the assump-
tions of unidimensionality, local independence, and
model appropriateness when analysing data by means of
IRT methods. Items which violate one or more of these
assumptions should be combined, rephrased, or deleted
[22,23], since they complicate the interpretation of
model outcomes. A promising observation was that the
majority of the studies tested the assumption of unidi-
mensionality and the appropriateness of the IRT model,
albeit some studies did not report any fit statistics.Although comparisons between unidimensional and
multidimensional IRT models provide a much more
rigorous test of unidimensionality than factor analyses,
such comparisons were not made. Analyses of model fit
mainly involved overall fit statistics or item fit statistics,
and to a lesser extent the evaluation of person fit. Person
fit, however, is also important since deviant response
patterns of patients may seriously affect the item fit. The
removal of patients with such response patterns from
the analysis may improve the scale’s internal construct
validity significantly [22]. Most studies, however, did not
check the assumption of local independence. The im-
portance of local independence has only more recently
been recognized and, consequently, only some of the
most recent studies (from the year 2007) did evaluate
this assumption. Future studies should continue to pay
attention to this assumption, since locally dependent
items could cause parameter estimates to be biased,
which may lead to wrong decisions concerning item se-
lection when constructing a certain outcome measure
[15].
The results also showed room for improvement in the
reporting of made choices and the rationale for specific
decisions. For instance, the applied IRT model is often
not specified and, if specified, the reasons behind the
selected IRT model and used estimation methods are
often not clearly motivated. This complicates the quality
appraisal and replication of performed analyses.
Where Belvedere and de Morton [8] examined the ap-
plication of Rasch analysis only, this study included the
whole spectrum of IRT models. A notable finding of this
review was that the Rasch models dominate within
rheumatology, and that two-parameter IRT models were
applied in only a few studies. This may be due to the
ease of use of a Rasch model and the easiness with
which its results can be interpreted. However, this ad-
vantage of Rasch modeling comes with the strict as-
sumption that every item of the measure is equally
discriminative. Whether this assumption is appropriate
can be tested by comparing the Rasch model fit with the
2-parameter model fit. Since the studies of Pham et al.
[65] and Siemons et al. [54] are the only studies in which
such a comparison was made, this is a point of interest
for future studies.
Although IRT is becoming increasingly popular in
health status assessment, IRT is quite complex to under-
stand and is not yet a main-stream technique for most
researchers and rheumatologists. To increase common
understanding and to improve the interpretation of out-
comes resulting from the performed IRT analyses, (bio)
statisticians, rheumatologists, and researchers should
closely collaborate. Clear guidelines on the quality ap-
praisal of performed IRT analyses might increase the use
and understanding of IRT in rheumatology even further.
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ing the methodological quality of the performed IRT
analyses. Although standardized tools like the COSMIN
(COnsensusbased Standards for the selection of health
status Measurement INstruments) checklist [66] can be
used for evaluating the methodological quality of studies
on measurement properties, this checklist only contains
a few questions regarding IRT analyses and is, therefore,
more suitable for analyzing the quality of performed
classical test theory analyses. Even though the quality
checklist used in this study was based on both expert in-
put and important issues from the literature, it was not
exhaustive and, consequently, it might have some limita-
tions. For example, when the sample size was consid-
ered, only the absolute number was reported. It was not
checked whether the authors also justified the sample
size for the analyses they wanted to perform. The vary-
ing sample size of the analysed patient groups which was
found between studies, might be due to the absence of
clear guidelines regarding sample size requirements. It is
argued that the most simple Rasch analyses already re-
quire a minimum size of 50–100 persons [15,23]. How-
ever, many issues are involved in determining the right
sample size for a certain study, including the model
choice, the number of response categories, and the pur-
pose of the study [15,23]. These issues should be care-
fully considered to determine the sample size which is
minimally needed to achieve reliable model estimates.
Consensus and clear guidelines on quality aspects con-
cerning IRT analyses might guide the choice of an ad-
equate sample size and might also stimulate the
development of uniform guidelines for performing and
reporting IRT studies, and the development of a check-
list for evaluating the quality of the performed and
reported IRT analyses.
The formulation of such guidelines will provide a
strong foundation to future IRT studies. Tennant et al.
already provided such guidelines for performing Rasch
analyses [22]. However, given the large diversity of
approaches, models, and software used in the field of
IRT it is difficult to recommend a single set of guidelines
for all types of studies, and an expansion or modification
of their guidelines might be needed. In order to get suffi-
cient support for these guidelines it is important to first
attempt to reach a more global consensus about recom-
mendations. This article could provide input for such
attempts and the COSMIN checklist [66] can serve as
an example of how such an international approach can
lead to the development of a consensus-based checklist.
Agreement should be reached on the minimum number
of assumptions which should be met (e.g. unidimension-
ality, model fit, and DIF analysis) and best ways of test-
ing these assumptions. Additionally, this review showed
that IRT methods are rarely being applied for theevaluation of an instrument’s local reliability and meas-
urement precision along the scale of the underlying con-
struct and the construction of item banks and CATs, all
unique features of IRT. Therefore, it is recommended
that more emphasis will be placed on these features in
the guidelines and in future studies.
Conclusions
A marked increase of IRT applications could be observed
within rheumatology. IRT has primarily been applied to
patient-reported outcomes, but it also appeared to be a
useful technique for the evaluation of clinical measures.
To date, IRT has mainly been used for the development
of new static outcome measures and the evaluation of
existing measures. In addition, alternate or short forms
were created by evaluating the fit and performance of in-
dividual items. Useful IRT applications which are not yet
widely used within rheumatology include the cross-
calibration of instrument scores and the development of
computerized adaptive tests which may reduce the
measurement burden for both the patient and the clin-
ician. Also, the measurement precision of outcome mea-
sures along the scale has only been evaluated
occasionally. The fact that IRT has not yet experienced
the same level of standardization and consensus on
methodology as CTT methods stresses the importance
to adequately explain, justify, and report performed IRT
analyses. A global consensus on uniform guidelines
should be reached about the minimum number of
assumptions which should be met and best ways of
testing these assumptions, in order to stimulate the quality
appraisal of performed and reported IRT analyses.
Additional files
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